31 Phosphorus Nuclear Magnetic Resonance Used in a Double Blind Trial of Allopurinol in Duchenne Muscular Dystrophy

Griffiths, R. D.; Cady, E.; Edwards, R. H. T.; Wilkie, D. R.

doi:10.1042/cs066020P_pt2

Article navigation

Conference Abstract| February 01 1984

31 Phosphorus Nuclear Magnetic Resonance Used in a Double Blind Trial of Allopurinol in Duchenne Muscular Dystrophy

R. D. Griffiths

Departments of Medicine and Physiology, University College London WC1E 6JJ

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

E. Cady

Departments of Medicine and Physiology, University College London WC1E 6JJ

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

R. H. T. Edwards

Departments of Medicine and Physiology, University College London WC1E 6JJ

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

D. R. Wilkie

Departments of Medicine and Physiology, University College London WC1E 6JJ

Search for other works by this author on:

This Site

PubMed

Google Scholar

Clin Sci (Lond) (1984) 66 (2): 20P.

https://doi.org/10.1042/cs066020P_pt2

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Portland Press
5th Floor, 90 High Holborn,
London WC1V 6LJ

Portland Press Tel
+44 (0)20 3880 2795
Biochemical Society Tel
+44 (0)20 3880 2793
Email: editorial@portlandpress.com

Privacy and cookies
Accessibility

31 Phosphorus Nuclear Magnetic Resonance Used in a Double Blind Trial of Allopurinol in Duchenne Muscular Dystrophy

Article PDF first page preview

Cited By

Get Email Alerts

CONNECT

EXPLORE

31 Phosphorus Nuclear Magnetic Resonance Used in a Double Blind Trial of Allopurinol in Duchenne Muscular Dystrophy

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Cited By

Get Email Alerts

Related Articles

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only